Skip to main content
. Author manuscript; available in PMC: 2018 Aug 16.
Published in final edited form as: Int J Trop Dis Health. 2017 Aug 28;25(2):IJTDH.35885. doi: 10.9734/IJTDH/2017/35885

Table 2.

Suspected MPX incidence in DRC (with and without the active surveillance areas), 2001–2013

Year Incidence, per 100,000, 95% CI Incidence per 100,000 (without active surveillance areas), 95% CI
2001 0.64 (0.09, 4.50) 0.61 (0.09, 4.30)
2002 1.4 (0.20, 9.90) 0.94 (0.13, 6.70)
2003 1.16 (0.16, 8.30) 0.72 (0.10, 5.10)
2004 1.53 (0.22, 10.90) 0.82 (0.12, 5.80)
2005 2.48 (0.35, 17.60) 0.96 (0.13, 6.80)
2006 1.11 (0.16, 7.80) 0.67 (0.09, 4.80)
2007 1.33 (0.19, 9.40) 0.60 (0.08, 4.20)
2008 2.13 (0.30, 15.10) 1.00 (0.15, 7.40)
2009 2.48 (0.35, 17.60) 1.20 (0.17, 8.80)
2010 2.91 (0.42, 20.70) 1.40 (0.19, 9.60)
2011 2.69 (0.38, 19.10) 1.60 (0.23, 11.60)
2012 3.11 (0.44, 22.10) 2.00 (0.28, 14.40)
2013 2.82 (0.40, 20.10) 1.50 (0.22, 10.90)